Lifecore Biomedical, Inc. Common Stock LFCR
i
Market dataready · fetched 2026-11-12T02:54:50.435Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:01.485529384Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T02:54:49.739890+00:00
Lifecore Biomedical, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 6.18 | 83.0% | 19.0% | |||
| 25Δ | 6.58 | 93.6% | 18.0% | |||
| 30Δ | 6.98 | 104.3% | 16.9% | |||
| 35Δ | 7.38 | 115.0% | 15.8% | |||
| 40Δ | 7.78 | 125.6% | 14.7% | |||
| 45Δ | 8.18 | 136.3% | 13.6% | |||
| 50Δ | 8.58 | 146.9% | 12.5% | |||
| 55Δ | 8.98 | 157.6% | 11.4% | |||
| 60Δ | 9.38 | 168.3% | 10.3% | |||
| 65Δ | 9.78 | 178.9% | 9.2% | |||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | 4.36 | 271.7% | 13.8% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.18
- IV
- 83.0%
- B/E move
- 19.0%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.58
- IV
- 93.6%
- B/E move
- 18.0%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.98
- IV
- 104.3%
- B/E move
- 16.9%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.38
- IV
- 115.0%
- B/E move
- 15.8%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.78
- IV
- 125.6%
- B/E move
- 14.7%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.18
- IV
- 136.3%
- B/E move
- 13.6%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.58
- IV
- 146.9%
- B/E move
- 12.5%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.98
- IV
- 157.6%
- B/E move
- 11.4%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.38
- IV
- 168.3%
- B/E move
- 10.3%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.78
- IV
- 178.9%
- B/E move
- 9.2%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 4.36
- IV
- 271.7%
- B/E move
- 13.8%
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Drug Manufacturers - Specialty & Generic
LNTH
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer…
More →LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is…
More →NBIX
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric…
More →OGI
Description unavailable
More →PAHC
Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The…
More →PBH
Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The…
More →